» Articles » PMID: 21827937

The Molecular Basis of Nutritional Intervention in Multiple Sclerosis: a Narrative Review

Overview
Publisher Elsevier
Date 2011 Aug 11
PMID 21827937
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

It is commonly accepted that nutrition is one of the possible environmental factors involved in the pathogenesis of multiple sclerosis (MS), but its role as complementary MS treatment is unclear and largely disregarded. At present, MS therapy is not associated to a particular diet, probably due to lack of information on the effects of nutrition on the disease. To overcome the distrust of the usefulness of dietary control in MS and to encourage nutritional interventions in the course of the disease, it is necessary to assess the nature and the role of bioactive dietary molecules and their targets, and establish how a dietary control can influence cell metabolism and improve the wellness of MS patients. The aim of this review is to provide a rationale for a nutritional intervention in MS by evaluating at the molecular level the effects of dietary molecules on the inflammatory and autoimmune processes involved in the disease. Present data reveal that healthy dietary molecules have a pleiotropic role and are able to change cell metabolism from anabolism to catabolism and down-regulate inflammation by interacting with enzymes, nuclear receptors and transcriptional factors. The control of gut dysbiosis and the combination of hypo-caloric, low-fat diets with specific vitamins, oligoelements and dietary integrators, including fish oil and polyphenols, may slow-down the progression of the disease and ameliorate the wellness of MS patients.

Citing Articles

Dietary Inflammatory Score (DIS)'s and Lifestyle Inflammatory Score (LIS)'s Impact on Multiple Sclerosis Severity.

Guglielmetti M, Ferraris C, Lopes Neri L, Frias-Toral E, Tagliabue A, Tavazzi E Nutrients. 2025; 17(3).

PMID: 39940384 PMC: 11819775. DOI: 10.3390/nu17030526.


Dietary Inflammatory Index score and its association with body mass index, body fat percentage, body fat mass, and lipid profile in patients with multiple sclerosis.

Kaya S, Uzdil Z, Shivappa N, Hebert J, Sokulmez Kaya P, Terzi M Turk J Med Sci. 2024; 53(5):1155-1165.

PMID: 38813018 PMC: 10763805. DOI: 10.55730/1300-0144.5681.


Association Between the Risk of Multiple Sclerosis and Dietary Proinflammatory/Anti-Inflammatory Food Intake and Dietary Diversity: A Case-Control Study.

Hatami A, Ahmadi-Khorram M, Keykhaei F, Esfehani A, Nematy M Clin Nutr Res. 2024; 13(1):61-73.

PMID: 38362132 PMC: 10866681. DOI: 10.7762/cnr.2024.13.1.61.


Role of fenofibrate in multiple sclerosis.

Abulaban A, Al-Kuraishy H, Al-Gareeb A, Elekhnawy E, Alanazi A, Alexiou A Eur J Med Res. 2024; 29(1):113.

PMID: 38336772 PMC: 10854163. DOI: 10.1186/s40001-024-01700-2.


The complex relationship between obesity and neurodegenerative diseases: an updated review.

Neto A, Fernandes A, Barateiro A Front Cell Neurosci. 2023; 17:1294420.

PMID: 38026693 PMC: 10665538. DOI: 10.3389/fncel.2023.1294420.